Approval · Notice of Compliance 34279 · 2024
ADVIL FLU: Notice of Compliance 34279
Issued October 25, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34279
- Date
- October 25, 2024
- Company
- Haleon Canada ULCMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Manufacturer and product name change. To update the Product Monograph with new Safety Information. Labelling Updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVIL FLU | 02401193 | Marketed |
Medicinal ingredients
- DIPHENHYDRAMINE HCL 25 MG per CAP
- IBUPROFEN 200 MG per CAP